Search Within

David Hyman

  1. "Maria Arcila"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (24)
Groups
  1. Department of Medicine (57)
  2. Department of Pathology and Laboratory Medicine (57)
  3. Early Drug Development Service (57)
  4. Solid Tumor Oncology Division (57)
  5. GSK Faculty (55)
  6. Human Oncology and Pathogenesis Program (49)

More Groups

People
  1. Maria Arcila (57)
  2. Michael Berger (41)
  3. Marc Ladanyi (38)
  4. David Solit (36)
  5. Ahmet Zehir (35)
  6. Jose Baselga (23)

More People

Years
  1. 2020 (4)
  2. 2019 (6)
  3. 2018 (8)
  4. 2017 (15)
  5. 2016 (7)
  6. 2015 (16)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Blood (6)
  3. Cancer Discovery (4)
  4. Cancer Research (3)
  5. Clinical Cancer Research (3)
  6. JAMA Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. American Association for Cancer Research (11)
  3. American Society of Hematology (6)
  4. Nature Publishing Group (6)
  5. American Medical Association (4)
  6. Nature Research (3)

More Publishers

Results (57)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in sporadic and familial histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Lopez-Rodrigo, E.; Abramson, D. H.; Picarsic, J.; Pastore, A.; Mandelker, D.; Walsh, M. F.; Arcila, M. E.; Ladanyi, M.; Solit, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors
    Journal Article

    Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; Bolton, K.; Yelskaya, Z.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
    Journal Article

    Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study
    Journal Article

    Diamond, E. L.; Subbiah, V.; Lockhart, A. C.; Blay, J. Y.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J.; Erinjeri, J. P.; Torrisi, J.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Accelerating discovery of functional mutant alleles in cancer
    Journal Article

    Chang, M. T.; Shrestha Bhattarai, T.; Schram, A. M.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; Chakravarty, D.; Phillips, S.; Kandoth, C.; Penson, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Characterization of NTRK fusions and therapeutic response to NTRK inhibition in hematologic malignancies
    Meeting Abstract

    Taylor, J.; Marcelus, C.; Pavlick, D.; Benayed, R.; Yoshimi, A.; Cocco, E.; Durham, B. H.; Hechtman, J. F.; Chung, Y. R.; Mullaney, K.; more...
    Blood (2017)

    Fulltext@MSK | Save